nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Methotrexate—colon cancer	0.229	0.315	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0871	0.12	CbGbCtD
Zaleplon—CYP3A7—Irinotecan—colon cancer	0.0871	0.12	CbGbCtD
Zaleplon—CYP3A7—Vincristine—colon cancer	0.0761	0.105	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0761	0.105	CbGbCtD
Zaleplon—CYP3A5—Irinotecan—colon cancer	0.0653	0.0901	CbGbCtD
Zaleplon—CYP3A5—Vincristine—colon cancer	0.0571	0.0787	CbGbCtD
Zaleplon—CYP3A4—Irinotecan—colon cancer	0.0255	0.0351	CbGbCtD
Zaleplon—CYP3A4—Vincristine—colon cancer	0.0223	0.0307	CbGbCtD
Zaleplon—AOX1—gall bladder—colon cancer	0.00184	0.0998	CbGeAlD
Zaleplon—TSPO—blood vessel—colon cancer	0.00167	0.0906	CbGeAlD
Zaleplon—TSPO—embryo—colon cancer	0.000996	0.054	CbGeAlD
Zaleplon—AOX1—renal system—colon cancer	0.000882	0.0479	CbGeAlD
Zaleplon—TSPO—epithelium—colon cancer	0.000813	0.0441	CbGeAlD
Zaleplon—CYP3A7—liver—colon cancer	0.00081	0.044	CbGeAlD
Zaleplon—TSPO—smooth muscle tissue—colon cancer	0.000783	0.0425	CbGeAlD
Zaleplon—TSPO—renal system—colon cancer	0.000754	0.0409	CbGeAlD
Zaleplon—AOX1—digestive system—colon cancer	0.000724	0.0393	CbGeAlD
Zaleplon—CYP3A7-CYP3A51P—liver—colon cancer	0.000689	0.0374	CbGeAlD
Zaleplon—AOX1—vagina—colon cancer	0.000639	0.0347	CbGeAlD
Zaleplon—TSPO—lymphoid tissue—colon cancer	0.000626	0.034	CbGeAlD
Zaleplon—TSPO—digestive system—colon cancer	0.000618	0.0335	CbGeAlD
Zaleplon—GABRA2—vagina—colon cancer	0.00059	0.032	CbGeAlD
Zaleplon—TSPO—bone marrow—colon cancer	0.00057	0.0309	CbGeAlD
Zaleplon—TSPO—vagina—colon cancer	0.000546	0.0296	CbGeAlD
Zaleplon—AOX1—liver—colon cancer	0.000539	0.0292	CbGeAlD
Zaleplon—Dry skin—Capecitabine—colon cancer	0.00052	0.00203	CcSEcCtD
Zaleplon—Alopecia—Irinotecan—colon cancer	0.000518	0.00202	CcSEcCtD
Zaleplon—Orthostatic hypotension—Capecitabine—colon cancer	0.000518	0.00202	CcSEcCtD
Zaleplon—Breast disorder—Capecitabine—colon cancer	0.000513	0.002	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000511	0.00199	CcSEcCtD
Zaleplon—Back pain—Vincristine—colon cancer	0.000507	0.00198	CcSEcCtD
Zaleplon—Flatulence—Irinotecan—colon cancer	0.000503	0.00196	CcSEcCtD
Zaleplon—Gastritis—Capecitabine—colon cancer	0.000502	0.00196	CcSEcCtD
Zaleplon—Muscular weakness—Capecitabine—colon cancer	0.0005	0.00195	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Capecitabine—colon cancer	0.0005	0.00195	CcSEcCtD
Zaleplon—Alopecia—Fluorouracil—colon cancer	0.000496	0.00194	CcSEcCtD
Zaleplon—Lymphadenopathy—Methotrexate—colon cancer	0.000495	0.00193	CcSEcCtD
Zaleplon—Back pain—Irinotecan—colon cancer	0.000494	0.00193	CcSEcCtD
Zaleplon—Asthma—Capecitabine—colon cancer	0.00049	0.00191	CcSEcCtD
Zaleplon—Dysphagia—Capecitabine—colon cancer	0.00049	0.00191	CcSEcCtD
Zaleplon—Thrombophlebitis—Methotrexate—colon cancer	0.000488	0.0019	CcSEcCtD
Zaleplon—Diabetes mellitus—Methotrexate—colon cancer	0.000485	0.00189	CcSEcCtD
Zaleplon—Anaemia—Vincristine—colon cancer	0.000484	0.00189	CcSEcCtD
Zaleplon—Agitation—Vincristine—colon cancer	0.000482	0.00188	CcSEcCtD
Zaleplon—Photosensitivity—Methotrexate—colon cancer	0.000481	0.00188	CcSEcCtD
Zaleplon—Angina pectoris—Capecitabine—colon cancer	0.000478	0.00186	CcSEcCtD
Zaleplon—Ill-defined disorder—Irinotecan—colon cancer	0.000474	0.00185	CcSEcCtD
Zaleplon—Anaemia—Irinotecan—colon cancer	0.000472	0.00184	CcSEcCtD
Zaleplon—Bronchitis—Capecitabine—colon cancer	0.000472	0.00184	CcSEcCtD
Zaleplon—Vertigo—Vincristine—colon cancer	0.000471	0.00184	CcSEcCtD
Zaleplon—CYP3A5—renal system—colon cancer	0.000467	0.0253	CbGeAlD
Zaleplon—TSPO—liver—colon cancer	0.000461	0.025	CbGeAlD
Zaleplon—Malaise—Irinotecan—colon cancer	0.00046	0.0018	CcSEcCtD
Zaleplon—Vertigo—Irinotecan—colon cancer	0.000459	0.00179	CcSEcCtD
Zaleplon—Dysuria—Capecitabine—colon cancer	0.000458	0.00179	CcSEcCtD
Zaleplon—Syncope—Irinotecan—colon cancer	0.000458	0.00179	CcSEcCtD
Zaleplon—Hypertension—Vincristine—colon cancer	0.000452	0.00176	CcSEcCtD
Zaleplon—Anaemia—Fluorouracil—colon cancer	0.000452	0.00176	CcSEcCtD
Zaleplon—Loss of consciousness—Irinotecan—colon cancer	0.000449	0.00175	CcSEcCtD
Zaleplon—Photosensitivity reaction—Capecitabine—colon cancer	0.000448	0.00175	CcSEcCtD
Zaleplon—Myalgia—Vincristine—colon cancer	0.000446	0.00174	CcSEcCtD
Zaleplon—Weight increased—Capecitabine—colon cancer	0.000446	0.00174	CcSEcCtD
Zaleplon—Weight decreased—Capecitabine—colon cancer	0.000444	0.00173	CcSEcCtD
Zaleplon—Hyperglycaemia—Capecitabine—colon cancer	0.000442	0.00172	CcSEcCtD
Zaleplon—Hypertension—Irinotecan—colon cancer	0.000441	0.00172	CcSEcCtD
Zaleplon—Pneumonia—Capecitabine—colon cancer	0.00044	0.00171	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Methotrexate—colon cancer	0.000436	0.0017	CcSEcCtD
Zaleplon—Depression—Capecitabine—colon cancer	0.000436	0.0017	CcSEcCtD
Zaleplon—Discomfort—Irinotecan—colon cancer	0.000429	0.00167	CcSEcCtD
Zaleplon—Neuropathy peripheral—Capecitabine—colon cancer	0.000429	0.00167	CcSEcCtD
Zaleplon—Anaphylactic shock—Vincristine—colon cancer	0.000428	0.00167	CcSEcCtD
Zaleplon—Oedema—Vincristine—colon cancer	0.000428	0.00167	CcSEcCtD
Zaleplon—Stomatitis—Capecitabine—colon cancer	0.000426	0.00166	CcSEcCtD
Zaleplon—Conjunctivitis—Capecitabine—colon cancer	0.000425	0.00166	CcSEcCtD
Zaleplon—Osteoarthritis—Methotrexate—colon cancer	0.000422	0.00165	CcSEcCtD
Zaleplon—Confusional state—Irinotecan—colon cancer	0.00042	0.00164	CcSEcCtD
Zaleplon—Nervous system disorder—Vincristine—colon cancer	0.000419	0.00164	CcSEcCtD
Zaleplon—GABRB3—liver—colon cancer	0.000418	0.0227	CbGeAlD
Zaleplon—Haematuria—Capecitabine—colon cancer	0.000417	0.00163	CcSEcCtD
Zaleplon—Anaphylactic shock—Irinotecan—colon cancer	0.000417	0.00162	CcSEcCtD
Zaleplon—Oedema—Irinotecan—colon cancer	0.000417	0.00162	CcSEcCtD
Zaleplon—Chest pain—Fluorouracil—colon cancer	0.000416	0.00162	CcSEcCtD
Zaleplon—Myalgia—Fluorouracil—colon cancer	0.000416	0.00162	CcSEcCtD
Zaleplon—Hyperhidrosis—Vincristine—colon cancer	0.000414	0.00161	CcSEcCtD
Zaleplon—Hepatobiliary disease—Capecitabine—colon cancer	0.000413	0.00161	CcSEcCtD
Zaleplon—AOX1—lymph node—colon cancer	0.000413	0.0224	CbGeAlD
Zaleplon—Epistaxis—Capecitabine—colon cancer	0.000412	0.00161	CcSEcCtD
Zaleplon—Discomfort—Fluorouracil—colon cancer	0.000411	0.0016	CcSEcCtD
Zaleplon—Shock—Irinotecan—colon cancer	0.00041	0.0016	CcSEcCtD
Zaleplon—Nervous system disorder—Irinotecan—colon cancer	0.000409	0.00159	CcSEcCtD
Zaleplon—Anorexia—Vincristine—colon cancer	0.000408	0.00159	CcSEcCtD
Zaleplon—Irritability—Methotrexate—colon cancer	0.000403	0.00157	CcSEcCtD
Zaleplon—Hyperhidrosis—Irinotecan—colon cancer	0.000403	0.00157	CcSEcCtD
Zaleplon—Confusional state—Fluorouracil—colon cancer	0.000402	0.00157	CcSEcCtD
Zaleplon—Mood swings—Methotrexate—colon cancer	0.0004	0.00156	CcSEcCtD
Zaleplon—Hypotension—Vincristine—colon cancer	0.0004	0.00156	CcSEcCtD
Zaleplon—Oedema—Fluorouracil—colon cancer	0.000399	0.00156	CcSEcCtD
Zaleplon—Anaphylactic shock—Fluorouracil—colon cancer	0.000399	0.00156	CcSEcCtD
Zaleplon—Anorexia—Irinotecan—colon cancer	0.000397	0.00155	CcSEcCtD
Zaleplon—Ataxia—Methotrexate—colon cancer	0.000397	0.00155	CcSEcCtD
Zaleplon—Nervous system disorder—Fluorouracil—colon cancer	0.000391	0.00153	CcSEcCtD
Zaleplon—Hypoaesthesia—Capecitabine—colon cancer	0.00039	0.00152	CcSEcCtD
Zaleplon—Liver function test abnormal—Methotrexate—colon cancer	0.00039	0.00152	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Vincristine—colon cancer	0.00039	0.00152	CcSEcCtD
Zaleplon—Tachycardia—Fluorouracil—colon cancer	0.000389	0.00152	CcSEcCtD
Zaleplon—Hypotension—Irinotecan—colon cancer	0.000389	0.00152	CcSEcCtD
Zaleplon—Insomnia—Vincristine—colon cancer	0.000387	0.00151	CcSEcCtD
Zaleplon—Oedema peripheral—Capecitabine—colon cancer	0.000387	0.00151	CcSEcCtD
Zaleplon—Paraesthesia—Vincristine—colon cancer	0.000384	0.0015	CcSEcCtD
Zaleplon—CYP3A5—digestive system—colon cancer	0.000383	0.0208	CbGeAlD
Zaleplon—Breast disorder—Methotrexate—colon cancer	0.000382	0.00149	CcSEcCtD
Zaleplon—GABRA2—lymph node—colon cancer	0.000381	0.0207	CbGeAlD
Zaleplon—Anorexia—Fluorouracil—colon cancer	0.00038	0.00148	CcSEcCtD
Zaleplon—Visual impairment—Capecitabine—colon cancer	0.000378	0.00147	CcSEcCtD
Zaleplon—Insomnia—Irinotecan—colon cancer	0.000377	0.00147	CcSEcCtD
Zaleplon—Paraesthesia—Irinotecan—colon cancer	0.000374	0.00146	CcSEcCtD
Zaleplon—Hypotension—Fluorouracil—colon cancer	0.000373	0.00145	CcSEcCtD
Zaleplon—Decreased appetite—Vincristine—colon cancer	0.000372	0.00145	CcSEcCtD
Zaleplon—Dyspnoea—Irinotecan—colon cancer	0.000371	0.00145	CcSEcCtD
Zaleplon—Somnolence—Irinotecan—colon cancer	0.00037	0.00144	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Vincristine—colon cancer	0.000369	0.00144	CcSEcCtD
Zaleplon—Eye disorder—Capecitabine—colon cancer	0.000367	0.00143	CcSEcCtD
Zaleplon—Dyspepsia—Irinotecan—colon cancer	0.000367	0.00143	CcSEcCtD
Zaleplon—Tinnitus—Capecitabine—colon cancer	0.000366	0.00143	CcSEcCtD
Zaleplon—Pain—Vincristine—colon cancer	0.000366	0.00143	CcSEcCtD
Zaleplon—Constipation—Vincristine—colon cancer	0.000366	0.00143	CcSEcCtD
Zaleplon—Asthma—Methotrexate—colon cancer	0.000365	0.00142	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000363	0.00142	CcSEcCtD
Zaleplon—Decreased appetite—Irinotecan—colon cancer	0.000362	0.00141	CcSEcCtD
Zaleplon—Eosinophilia—Methotrexate—colon cancer	0.000361	0.00141	CcSEcCtD
Zaleplon—Insomnia—Fluorouracil—colon cancer	0.000361	0.00141	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Irinotecan—colon cancer	0.00036	0.0014	CcSEcCtD
Zaleplon—Paraesthesia—Fluorouracil—colon cancer	0.000358	0.0014	CcSEcCtD
Zaleplon—Pain—Irinotecan—colon cancer	0.000356	0.00139	CcSEcCtD
Zaleplon—Constipation—Irinotecan—colon cancer	0.000356	0.00139	CcSEcCtD
Zaleplon—Dyspnoea—Fluorouracil—colon cancer	0.000356	0.00139	CcSEcCtD
Zaleplon—Somnolence—Fluorouracil—colon cancer	0.000355	0.00138	CcSEcCtD
Zaleplon—Immune system disorder—Capecitabine—colon cancer	0.000354	0.00138	CcSEcCtD
Zaleplon—TSPO—lymph node—colon cancer	0.000353	0.0192	CbGeAlD
Zaleplon—Chills—Capecitabine—colon cancer	0.000352	0.00137	CcSEcCtD
Zaleplon—Dyspepsia—Fluorouracil—colon cancer	0.000351	0.00137	CcSEcCtD
Zaleplon—CYP3A4—renal system—colon cancer	0.00035	0.019	CbGeAlD
Zaleplon—Gastrointestinal pain—Vincristine—colon cancer	0.00035	0.00136	CcSEcCtD
Zaleplon—Decreased appetite—Fluorouracil—colon cancer	0.000347	0.00135	CcSEcCtD
Zaleplon—Alopecia—Capecitabine—colon cancer	0.000347	0.00135	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000344	0.00134	CcSEcCtD
Zaleplon—Mental disorder—Capecitabine—colon cancer	0.000344	0.00134	CcSEcCtD
Zaleplon—Feeling abnormal—Irinotecan—colon cancer	0.000343	0.00134	CcSEcCtD
Zaleplon—Malnutrition—Capecitabine—colon cancer	0.000342	0.00133	CcSEcCtD
Zaleplon—Dysuria—Methotrexate—colon cancer	0.000341	0.00133	CcSEcCtD
Zaleplon—Pain—Fluorouracil—colon cancer	0.000341	0.00133	CcSEcCtD
Zaleplon—Gastrointestinal pain—Irinotecan—colon cancer	0.000341	0.00133	CcSEcCtD
Zaleplon—Body temperature increased—Vincristine—colon cancer	0.000338	0.00132	CcSEcCtD
Zaleplon—Abdominal pain—Vincristine—colon cancer	0.000338	0.00132	CcSEcCtD
Zaleplon—CYP3A5—vagina—colon cancer	0.000338	0.0183	CbGeAlD
Zaleplon—Flatulence—Capecitabine—colon cancer	0.000337	0.00131	CcSEcCtD
Zaleplon—Erectile dysfunction—Methotrexate—colon cancer	0.000336	0.00131	CcSEcCtD
Zaleplon—Dysgeusia—Capecitabine—colon cancer	0.000335	0.0013	CcSEcCtD
Zaleplon—Photosensitivity reaction—Methotrexate—colon cancer	0.000333	0.0013	CcSEcCtD
Zaleplon—Back pain—Capecitabine—colon cancer	0.00033	0.00129	CcSEcCtD
Zaleplon—Abdominal pain—Irinotecan—colon cancer	0.000329	0.00128	CcSEcCtD
Zaleplon—Body temperature increased—Irinotecan—colon cancer	0.000329	0.00128	CcSEcCtD
Zaleplon—Feeling abnormal—Fluorouracil—colon cancer	0.000329	0.00128	CcSEcCtD
Zaleplon—Pneumonia—Methotrexate—colon cancer	0.000327	0.00128	CcSEcCtD
Zaleplon—Depression—Methotrexate—colon cancer	0.000324	0.00127	CcSEcCtD
Zaleplon—Tremor—Capecitabine—colon cancer	0.00032	0.00125	CcSEcCtD
Zaleplon—Stomatitis—Methotrexate—colon cancer	0.000317	0.00124	CcSEcCtD
Zaleplon—Ill-defined disorder—Capecitabine—colon cancer	0.000317	0.00124	CcSEcCtD
Zaleplon—Urticaria—Fluorouracil—colon cancer	0.000317	0.00124	CcSEcCtD
Zaleplon—Conjunctivitis—Methotrexate—colon cancer	0.000316	0.00123	CcSEcCtD
Zaleplon—Anaemia—Capecitabine—colon cancer	0.000316	0.00123	CcSEcCtD
Zaleplon—Body temperature increased—Fluorouracil—colon cancer	0.000315	0.00123	CcSEcCtD
Zaleplon—Sweating—Methotrexate—colon cancer	0.000312	0.00122	CcSEcCtD
Zaleplon—Haematuria—Methotrexate—colon cancer	0.00031	0.00121	CcSEcCtD
Zaleplon—Malaise—Capecitabine—colon cancer	0.000308	0.0012	CcSEcCtD
Zaleplon—Hepatobiliary disease—Methotrexate—colon cancer	0.000308	0.0012	CcSEcCtD
Zaleplon—Epistaxis—Methotrexate—colon cancer	0.000307	0.0012	CcSEcCtD
Zaleplon—Vertigo—Capecitabine—colon cancer	0.000307	0.0012	CcSEcCtD
Zaleplon—Asthenia—Vincristine—colon cancer	0.000307	0.0012	CcSEcCtD
Zaleplon—Syncope—Capecitabine—colon cancer	0.000306	0.00119	CcSEcCtD
Zaleplon—Palpitations—Capecitabine—colon cancer	0.000302	0.00118	CcSEcCtD
Zaleplon—Loss of consciousness—Capecitabine—colon cancer	0.0003	0.00117	CcSEcCtD
Zaleplon—Asthenia—Irinotecan—colon cancer	0.000299	0.00117	CcSEcCtD
Zaleplon—Hypertension—Capecitabine—colon cancer	0.000295	0.00115	CcSEcCtD
Zaleplon—Myalgia—Capecitabine—colon cancer	0.000291	0.00113	CcSEcCtD
Zaleplon—Arthralgia—Capecitabine—colon cancer	0.000291	0.00113	CcSEcCtD
Zaleplon—Chest pain—Capecitabine—colon cancer	0.000291	0.00113	CcSEcCtD
Zaleplon—Anxiety—Capecitabine—colon cancer	0.00029	0.00113	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000289	0.00113	CcSEcCtD
Zaleplon—Discomfort—Capecitabine—colon cancer	0.000287	0.00112	CcSEcCtD
Zaleplon—CYP3A4—digestive system—colon cancer	0.000287	0.0156	CbGeAlD
Zaleplon—CYP3A5—liver—colon cancer	0.000285	0.0155	CbGeAlD
Zaleplon—Dry mouth—Capecitabine—colon cancer	0.000284	0.00111	CcSEcCtD
Zaleplon—Dizziness—Vincristine—colon cancer	0.000283	0.0011	CcSEcCtD
Zaleplon—Pruritus—Fluorouracil—colon cancer	0.000282	0.0011	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—colon cancer	0.000282	0.0011	CcSEcCtD
Zaleplon—Confusional state—Capecitabine—colon cancer	0.000281	0.0011	CcSEcCtD
Zaleplon—Oedema—Capecitabine—colon cancer	0.000279	0.00109	CcSEcCtD
Zaleplon—Dizziness—Irinotecan—colon cancer	0.000275	0.00107	CcSEcCtD
Zaleplon—Shock—Capecitabine—colon cancer	0.000274	0.00107	CcSEcCtD
Zaleplon—Nervous system disorder—Capecitabine—colon cancer	0.000273	0.00107	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—colon cancer	0.000273	0.00106	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—colon cancer	0.000272	0.00106	CcSEcCtD
Zaleplon—Tachycardia—Capecitabine—colon cancer	0.000272	0.00106	CcSEcCtD
Zaleplon—Skin disorder—Capecitabine—colon cancer	0.000271	0.00106	CcSEcCtD
Zaleplon—Rash—Vincristine—colon cancer	0.00027	0.00105	CcSEcCtD
Zaleplon—Hyperhidrosis—Capecitabine—colon cancer	0.00027	0.00105	CcSEcCtD
Zaleplon—Dermatitis—Vincristine—colon cancer	0.000269	0.00105	CcSEcCtD
Zaleplon—Headache—Vincristine—colon cancer	0.000268	0.00105	CcSEcCtD
Zaleplon—Anorexia—Capecitabine—colon cancer	0.000266	0.00104	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—colon cancer	0.000264	0.00103	CcSEcCtD
Zaleplon—Dizziness—Fluorouracil—colon cancer	0.000264	0.00103	CcSEcCtD
Zaleplon—Rash—Irinotecan—colon cancer	0.000263	0.00102	CcSEcCtD
Zaleplon—Dermatitis—Irinotecan—colon cancer	0.000262	0.00102	CcSEcCtD
Zaleplon—Chills—Methotrexate—colon cancer	0.000262	0.00102	CcSEcCtD
Zaleplon—Headache—Irinotecan—colon cancer	0.000261	0.00102	CcSEcCtD
Zaleplon—Hypotension—Capecitabine—colon cancer	0.000261	0.00102	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—colon cancer	0.000258	0.00101	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—colon cancer	0.000256	0.000998	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—colon cancer	0.000254	0.000992	CcSEcCtD
Zaleplon—Nausea—Vincristine—colon cancer	0.000254	0.000991	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000254	0.000991	CcSEcCtD
Zaleplon—Insomnia—Capecitabine—colon cancer	0.000252	0.000983	CcSEcCtD
Zaleplon—Rash—Fluorouracil—colon cancer	0.000252	0.000981	CcSEcCtD
Zaleplon—Dermatitis—Fluorouracil—colon cancer	0.000251	0.00098	CcSEcCtD
Zaleplon—Paraesthesia—Capecitabine—colon cancer	0.00025	0.000976	CcSEcCtD
Zaleplon—Headache—Fluorouracil—colon cancer	0.00025	0.000975	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—colon cancer	0.000249	0.000971	CcSEcCtD
Zaleplon—Dyspnoea—Capecitabine—colon cancer	0.000249	0.000969	CcSEcCtD
Zaleplon—Nausea—Irinotecan—colon cancer	0.000247	0.000965	CcSEcCtD
Zaleplon—Back pain—Methotrexate—colon cancer	0.000246	0.000959	CcSEcCtD
Zaleplon—Dyspepsia—Capecitabine—colon cancer	0.000245	0.000957	CcSEcCtD
Zaleplon—Decreased appetite—Capecitabine—colon cancer	0.000242	0.000945	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Capecitabine—colon cancer	0.000241	0.000939	CcSEcCtD
Zaleplon—Pain—Capecitabine—colon cancer	0.000238	0.00093	CcSEcCtD
Zaleplon—Constipation—Capecitabine—colon cancer	0.000238	0.00093	CcSEcCtD
Zaleplon—Nausea—Fluorouracil—colon cancer	0.000237	0.000924	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—colon cancer	0.000236	0.00092	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—colon cancer	0.000235	0.000917	CcSEcCtD
Zaleplon—Feeling abnormal—Capecitabine—colon cancer	0.00023	0.000896	CcSEcCtD
Zaleplon—Malaise—Methotrexate—colon cancer	0.000229	0.000894	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—colon cancer	0.000228	0.000891	CcSEcCtD
Zaleplon—Gastrointestinal pain—Capecitabine—colon cancer	0.000228	0.000889	CcSEcCtD
Zaleplon—Urticaria—Capecitabine—colon cancer	0.000221	0.000864	CcSEcCtD
Zaleplon—Abdominal pain—Capecitabine—colon cancer	0.00022	0.00086	CcSEcCtD
Zaleplon—Body temperature increased—Capecitabine—colon cancer	0.00022	0.00086	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—colon cancer	0.000217	0.000844	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—colon cancer	0.000217	0.000844	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—colon cancer	0.000217	0.000844	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000215	0.000839	CcSEcCtD
Zaleplon—CYP3A4—liver—colon cancer	0.000214	0.0116	CbGeAlD
Zaleplon—Discomfort—Methotrexate—colon cancer	0.000214	0.000834	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—colon cancer	0.000209	0.000816	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—colon cancer	0.000208	0.000809	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—colon cancer	0.000204	0.000794	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—colon cancer	0.000202	0.000786	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—colon cancer	0.000201	0.000783	CcSEcCtD
Zaleplon—Asthenia—Capecitabine—colon cancer	0.0002	0.00078	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—colon cancer	0.000198	0.000772	CcSEcCtD
Zaleplon—Pruritus—Capecitabine—colon cancer	0.000197	0.000769	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—colon cancer	0.000194	0.000756	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000189	0.000737	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—colon cancer	0.000188	0.000732	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—colon cancer	0.000186	0.000727	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—colon cancer	0.000185	0.000722	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—colon cancer	0.000185	0.00072	CcSEcCtD
Zaleplon—Dizziness—Capecitabine—colon cancer	0.000184	0.000719	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—colon cancer	0.000183	0.000713	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—colon cancer	0.00018	0.000704	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—colon cancer	0.000179	0.000699	CcSEcCtD
Zaleplon—Pain—Methotrexate—colon cancer	0.000177	0.000692	CcSEcCtD
Zaleplon—Rash—Capecitabine—colon cancer	0.000176	0.000686	CcSEcCtD
Zaleplon—Dermatitis—Capecitabine—colon cancer	0.000176	0.000685	CcSEcCtD
Zaleplon—Headache—Capecitabine—colon cancer	0.000175	0.000681	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—colon cancer	0.000171	0.000667	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—colon cancer	0.00017	0.000662	CcSEcCtD
Zaleplon—Nausea—Capecitabine—colon cancer	0.000166	0.000646	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—colon cancer	0.000165	0.000643	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—colon cancer	0.000164	0.00064	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—colon cancer	0.000164	0.00064	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—colon cancer	0.000149	0.000581	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—colon cancer	0.000147	0.000573	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—colon cancer	0.000137	0.000535	CcSEcCtD
Zaleplon—Rash—Methotrexate—colon cancer	0.000131	0.00051	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—colon cancer	0.000131	0.00051	CcSEcCtD
Zaleplon—Headache—Methotrexate—colon cancer	0.00013	0.000507	CcSEcCtD
Zaleplon—Nausea—Methotrexate—colon cancer	0.000123	0.000481	CcSEcCtD
